市場調査レポート

商品コード

1622451

解剖病理学の市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2025～2032年

Anatomic Pathology Market Size, Share, Growth Analysis, By Product (Instruments, Consumables), By Application (Disease Diagnostics, Medical Research), By End Use, By Region - Industry Forecast 2025-2032

出版日: 2024年12月22日
発行: SkyQuest
ページ情報: 英文 265 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 795,318円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 930,372円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,065,426円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

解剖病理学の市場規模は、2023年に377億1,000万米ドルと評価され、2024年の404億6,000万米ドルから2032年には703億2,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは7.3％で成長する見通しです。

世界の解剖病理学市場は、臨床的な意思決定を強化し、患者の転帰を改善する疾患発症のための臨床バイオマーカーの利用増加により、堅調な成長が見込まれています。特にインドや中国のような開発途上国では、バイオマーカーに基づく病理学的検査の普及と先端技術の導入が進んでおり、この需要がさらに高まっています。デジタル顕微鏡や染色システムを含む病理検査機器の著しい進歩も市場拡大に寄与しています。特に、OptraSCANのような企業は、分析プロセスを合理化するインテリジェントなソリューションで革新を進めています。Royal PhilipsとIbex Medical Analyticsのようなコラボレーションは、AIを病理学に統合し、イノベーションを促進し、製品ポートフォリオを拡大することを目的としており、予測期間を通じてこの分野の継続的な成長を確実なものにしています。

市場概要
機器
- スライド染色システム
- 組織処理システム
- Cellプロセッサ
- ミクロトームとクライオスタット
- 埋め込みシステム
- カバースリッパ
- その他の製品
消耗品
- 抗体
- 一次抗体
- 二次抗体
- キットと試薬
- 汚れと溶剤
- 定着剤
- その他のキットと試薬
- プローブ
- その他の消耗品
サービス
- 組織病理学サービス
- 細胞病理学サービス

解剖病理学市場規模：用途別

市場概要
病気の診断
- がん
- 乳がん
- 消化器がん
- 肺がん
- 前立腺がん
- その他のがん
- その他の病気
医学調査
医薬品の発見と開発
その他

解剖病理学市場規模：最終用途別

市場概要
病院
臨床検査室
診断検査室
その他

解剖病理学市場規模

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

F. Hoffman-LA Roche Ltd.
Danaher Corporation
PHC Holdings Corporation
Abcam Plc.
Hologic, Inc.
Agilent Technologies
Becton, Dickinson And Company
Sakura Finetek Usa Inc.
Merck Kgaa
Bio SB
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Cardinal Health
NeoGenomics Laboratories, Inc.
BioGenex
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens AG
Cell Signaling Technology, Inc.
PerkinElmer Inc.

結論と推奨事項

Product Code: SQMIG35E2013

Anatomic Pathology Market size was valued at USD 37.71 Billion in 2023 and is poised to grow from USD 40.46 Billion in 2024 to USD 70.32 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The global anatomic pathology market is poised for robust growth, driven by the increased utilization of clinical biomarkers for disease pathogenesis, which enhances clinical decision-making and improves patient outcomes. The rising prevalence of biomarker-based pathology tests and advanced technology adoption, particularly in developing nations like India and China, further fuels this demand. Significant advancements in pathology equipment, including digital microscopes and staining systems, are also contributing to market expansion. Notably, companies like OptraSCAN are innovating with intelligent solutions to streamline analysis processes. Collaborations, such as that between Royal Philips and Ibex Medical Analytics, aim to integrate AI into pathology, fostering innovation and broadening product portfolios, thus ensuring continued growth in this sector through the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Anatomic Pathology Market Segmental Analysis

Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Anatomic Pathology Market

The anatomic pathology market is poised for significant growth, primarily driven by the rising incidence of various chronic diseases and evolving consumer lifestyles and dietary habits. Our research indicates that the global population aged 65 and older was approximately 727 million in 2020 and is projected to double to 1.5 billion by 2050. This substantial increase in the elderly demographic is anticipated to generate considerable opportunities for the anatomic pathology market in the near future. As a result, the combination of demographic shifts and the growing burden of chronic conditions will be key factors propelling market expansion throughout the forecast period.

Restraints in the Anatomic Pathology Market

One significant restraint impacting the anatomic pathology market is the limited availability of refurbished anatomic pathology equipment globally. This scarcity poses a challenge, particularly for small and medium-sized hospitals and laboratories that prioritize cost-effectiveness in their investments. As these end users often opt for refurbished equipment to meet their budget constraints, the lack of supply in this segment is anticipated to hinder the overall growth of the anatomic pathology market during the projected period. Therefore, addressing the shortage of affordable, refurbished options is crucial for fostering a more robust market environment.

Market Trends of the Anatomic Pathology Market

The anatomic pathology market is experiencing a notable shift towards advanced technological solutions, driven by the increasing adoption of digital microscopes, staining systems, and gross imaging tools. These innovations offer enhanced accuracy and specificity compared to traditional methods, revolutionizing diagnostic processes. As healthcare providers seek to improve patient outcomes through more reliable and efficient pathology solutions, the demand for sophisticated anatomic pathology equipment is surging. This trend underscores a broader movement towards digitalization and automation in healthcare, presenting lucrative growth opportunities for manufacturers and service providers in the anatomic pathology sector over the next few years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree Of Competition
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2024
Pestel Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Assessment
Regulatory Landscape
Pipeline Analysis
Disease Epidemiology
Patent Analysis

Global Anatomic Pathology Market Size by Product & Services & CAGR (2025-2032)

Market Overview
Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- Microtomes & Cryostat
- Embedding Systems
- Cover Slippers
- Other Products
Consumables
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Kits And Reagents
- Stains And Solvents
- Fixatives
- Other Kits and Reagents
- Probes
- Other Consumables
Services
- Histopathology Services
- Cytopathology Services

Global Anatomic Pathology Market Size by Application & CAGR (2025-2032)

Market Overview
Disease Diagnostics
- Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
- Other Diseases
Medical Research
Drug Discovery and Development
Others

Global Anatomic Pathology Market Size by End Use & CAGR (2025-2032)

Market Overview
Hospitals
Clinical Laboratories
Diagnostic Laboratories
Others

Global Anatomic Pathology Market Size & CAGR (2025-2032)

North America (Product & Services, Application, End Use)
- US
- Canada
Europe (Product & Services, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Services, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Services, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Services, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

F. Hoffman-LA Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam Plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson And Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sakura Finetek Usa Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Kgaa
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio SB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments